Navigation Links
Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial

ing its product candidates; the company's ability to obtain additional funding required to conduct its research, development and commercialization activities; the company's dependence on its collaboration with Novartis Pharma AG; the ability of the company to attract and retain qualified personnel; competition in general; the company's ability to obtain, maintain and enforce patent and other intellectual property protection for its product candidates and its discoveries and the Company's ability to accurately assess the market. These and other risks which may impact management's expectations are described in greater detail under the caption "Risk Factors" in the company's annual report on Form 10-K for the year ended December 31, 2006 and filed with the Securities and Exchange Commission, the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2007 and other filings that the company makes with the Securities and Exchange Commission.

All forward-looking statements reflect the company's expectations only as of the date of this release and should not be relied upon as reflecting the company's views, expectations or beliefs at any date subsequent to the date of this release. Idenix anticipates that subsequent events and developments may cause these views, expectations and beliefs to change. However, while Idenix may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so.

(1) Center For Disease Control National Prevention Strategy.

(2) Center for Disease Control. Hepatitis C Fact Sheet accessed online at http://www.cdc.gov/ncidod/diseases/hepatitis/c/fact.htm.

(3) Davis, G. et al., Projecting Future Complications of Chronic Hepatitis C in the United States. Liver Transplantation, April 2003.

Idenix Pharmaceuticals' Contacts:

Media: Teri Dahlman (617) 99
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Idenix Reports Results from Two Phase IIb Studies of the Combination of Valopicitabine and Pegylated Interferon in Hepatitis C Genotype-1 Patients at the 42nd Annual Meeting of the European Association for the Study of the Liver
2. New Data Show Pfizers Axitinib Prolonged Overall Survival in Advanced Pancreatic Cancer When Combined with Standard of Care Chemotherapy
3. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
4. Low-Dose Steroid Combined With Lenalidomide Prolongs Survival Compared With High-Dose Steroid for Multiple Myeloma Treatment
5. RTA 402 Shown to Protect Animals Against Toxicities of Standard Cancer Treatments
6. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
7. Repros Reports That Proellex Has Demonstrated Superior Efficacy and Safety in Endometriosis When Compared to Standard of Drug Care
8. Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death
9. Clinical Trial Results Change Standard of Care for Pancreatic Cancer Patients, Future Therapies Discussed
10. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
11. Phase 2 Clinical Results of Ganite Plus Standard Therapy in Patients with Relapsed/Refractory Lymphoma Presented at ASCO
Post Your Comments:
(Date:4/30/2015)... April 30, 2015  Thoratec Corporation (NASDAQ: THOR ... to save, support and restore failing hearts, said today ... Lynch 2015 Healthcare Conference on Thursday, May 14. ... Executive Officer, will provide an update on the company, ... Eastern Daylight Time). The presentation will be ...
(Date:4/30/2015)... -- DURECT Corporation (Nasdaq: DRRX ) announced today financial ... were $4.8 million and net loss was $4.9 million ... compared to total revenues of $6.3 million and net ... March 31, 2014.At March 31, 2015, we had cash ... investments of $34.9 million at December 31, 2014.  Subsequent ...
(Date:4/30/2015)... Company plc (NYSE: PRGO ; TASE) today announced that Perrigo ... at the 2015 Deutsche Bank 40 th Annual Healthcare Conference ... Hotel in Boston , MA.  ... Joseph C. Papa will present at the Bank of America ... 12, 2015 at the Encore at Wynn Las Vegas Hotel in ...
Breaking Medicine Technology:Thoratec Presentation At Bank Of America Merrill Lynch Healthcare Conference To Be Webcast 2DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 2DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 3DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 4DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 5DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 6DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 7DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 8DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 9Perrigo Company To Present At Upcoming Healthcare Conferences 2Perrigo Company To Present At Upcoming Healthcare Conferences 3
... April 12, 2011 Havel,s market leading EchoStim® ... allows practitioners to perform Peripheral Nerve Blocks (PNBs) ... same time.  The new improved needle has more, ... ultrasound easier, giving even inexperienced practitioners the benefits ...
... April 12, 2011 Perrigo (Nasdaq: PRGO ; ... and Drug Administration (FDA) has concluded its re-inspection of Perrigo,s ... the Company has an acceptable regulatory status, such that any ... once again be eligible for review and approval. ...
Cached Medicine Technology:Perrigo Announces Conclusion of the FDA Re-Inspection 2
(Date:5/2/2015)... “ ActOn ” was featured on NewsWatch as ... the latest and coolest applications on the market for iOS, ... technology expert, conducted the app review and shared with viewers ... to make a difference. , In this material world, almost ... aren’t about money, which is why those things should be ...
(Date:5/2/2015)... 02, 2015 On Tuesday April 7th, ... (ELCH) gathered to celebrate improvements in patient care. In ... Partners (RVHP), had zero acquired ventilator associated infections, zero ... infections. ELCH was also recently named a Top Performer ... at ELCH credited the teamwork of staff from all ...
(Date:5/1/2015)... IDLife LLC, a health and wellness company headquartered ... of its newest partner and fitness celebrity, Jen Widerstrom. ... up in gymnastics and competitive diving, but truly found ... trainer and helping others achieve their fitness aspirations. Jen ... highlighting her stunning physique and unique training techniques. ...
(Date:5/1/2015)... May 01, 2015 The Workgroup ... nonprofit authority on the use of health IT to ... key contributing resource to the United States Government Accountability ... electronically readable cards in Medicare. The report, “ Potential ... ” was released to the public on Apr. 24, ...
(Date:5/1/2015)... CA (PRWEB) May 01, 2015 The ... genetic makeup and the interplay of genes with one ... with developments can be daunting. , LabRoots, the premier ... clinical diagnostics professionals, will soon host its annual conference ... At BioConference Live Genetics and Genomics 2015 , ...
Breaking Medicine News(10 mins):Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2Health News:IDLife LLC Announces New Partnership with Fitness Celebrity, Jen Widerstrom 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 3
... curious contagious cancer, found in dogs, wolves and coyotes, can ... host animal, according to a new study in the journal ... uncovered an unusual process that helps the cancer survive by ... of the infected animal, to incorporate as its own. They ...
... Gardner HealthDay Reporter , THURSDAY, Jan. 20 (HealthDay ... differently depending on what side of the Atlantic you,re ... flu still predominated in Britain, where 112 people have died, ... some doctors report running out of vaccine, according to the ...
... in Medicine (AIUM) announced today that ultrasound practice accreditation ... the standard for care in fetal echocardiography and builds ... its safe and effective use. "I am proud ... to show that they meet or exceed training and ...
... for your health is not new, but is it really ... Psychological Science , a journal of the Association for Psychological ... influence health outcomes in later adulthood. "We all ... quality of our lives," said Anthony Ong of Cornell University, ...
... A new study published in The American Journal ... (human growth hormone) has become common among young American ... is often associated with polysubstance abuse involving both performance-enhancing ... drug used exclusively by elite athletes, has become cheaply ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, ... of bedbugs believe they know how the critters become ... drive them from homes, stores and offices across the ... genetic makeup of the bedbug," said lead researcher Omprakash ...
Cached Medicine News:Health News:Contagious cancer thrives in dogs by adopting host's genes 2Health News:H1N1 Flu Is Raging in Britain; Could U.S. Be Next? 2Health News:H1N1 Flu Is Raging in Britain; Could U.S. Be Next? 3Health News:AIUM announces ultrasound practice accreditation in fetal echocardiography 2Health News:Bedbugs Reveal Their Genetic Secrets in Lab Study 2Health News:Bedbugs Reveal Their Genetic Secrets in Lab Study 3
Otoscope with 4X magnification lens, swivellable to both sides, with removable cover glass to insert external instruments. Sealed system allowing for pneumatic otoscopy. 2.5V halogen source....
Designed for instrumentation under magnification. Both lens and speculum can be swivelled. Open construction to allow access and examination under magnification and illumination....
Pocket-sized instrument, powered by two AA-sized alkaline batteries. Built-in throat illuminator, rectangular viewing lens for instrumentation under magnification....
Provides 30% more magnification and twice the field of view. Adjustable focus....
Medicine Products: